Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Addnode Group provides update on corona pandemic impact, withdraws dividend proposal and announces cost savings measures

March 30, 2020, StockholmAlthough Addnode Group believes that the direct financial effects during the first quarter of 2020 will be limited, Addnode Group has identified a need to manage future effects on our operations as a result of the corona pandemic. At present, it is not possible to determine how large or long-lasting the corona pandemic effect is. Revoked dividend proposal Addnode Group has a strong financial position, but as a consequence of the uncertainty due to the corona pandemic, the Board of Addnode Group AB (publ) has decided to withdraw the previously announced

Bambuser publishes prospectus regarding the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. The prospectus regarding Bambuser AB’s (”Bambuser” or the ”Company”) rights issue of approximately SEK 101,1 million has today, 30 March 2020, been approved and registered by the Swedish Financial Supervisory Authority, and is available on

Bergs Timber restructures the Swedish sawmill business

A strategic review of the Swedish sawmill business has been carried out during the winter in order to create opportunities for long term profitability. The plan clearly indicates the potential to concentrate efforts in development and investments to three of the today’s four sawmills. In light of this plan, the Board of Directors of Bergs Timber has decided to immediately initiate discussion with the unions to close Gransjö sawmill. The sawmilling business will cease as soon as possible and the remaining business during the autumn 2020. The closure will affect about 45 employees. ”We

Bergs Timber postpones the annual general meeting and withdraws the proposed dividend

The Board of Directors of Bergs Timber AB has today, as a result of the spread of the corona virus, taken the decision to postpone the annual general meeting to a later date. Bergs Timber will publish an invitation to the annual general meeting no later than four weeks prior to the new date. The annual general meeting will be held, at the latest, on June 30 2020 in accordance with existing legislation. The Board of Directors has decided to withdraw the proposed dividend of SEK 0.04 per share, in total approximately SEK 14 million. The board´s decision has been taken in light of the

Mehiläinen Yhtiöt Oy supplements the tender offer document dated 8 January 2020 regarding the public cash tender offer for all shares in Pihlajalinna Plc

THIS STOCK EXCHANGE RELEASE MAY NOT BE RELEASED, PUBLISHED OR OTHERWISE DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, OR SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. Mehiläinen Yhtiöt Oy supplements the tender offer document dated 8 January 2019 regarding the public cash tender offer for all shares in

The Nomination Committee proposes unchanged ordinary directors’ fees for 2020

As an act of solidarity in these times, the Nomination Committee proposes unchanged ordinary directors’ fees to the members of the Board of Directors.In light of this, the Nomination Committee will withdraw its proposal on increased fees to the Board of Directors. Instead, the Nomination Committee proposes unchanged ordinary fees to the members of the Board of Directors, which means SEK 740,000 to the Chairman of the Board, SEK 260,000 to the Vice Chairman and SEK 160,000 to each of the other Board members. Anders Oscarsson, Head of Equity & Head of Corporate Governance at AMF and a

Calliditas moves its Annual General Meeting 2020 to June 25

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that due to the recent Covid-19 pandemic, the Company has decided to move its Annual General Meeting 2020 to June 25, 2020.The Annual Report for 2019 is expected to be published on April 28, 2020. The information was sent for publication, through the agency of the contact persons set out above, on March 30, 2020 at 2:00 p.m. CET. For further information, please contact: Renée Aguiar-Lucander, CEO, Calliditas Email: renee.lucander@calliditas.com Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications

Aker Solutions Secures Brownfield Services Contract in Brunei

March 30, 2020 - Aker Solutions, in a joint venture with PTAS Sdn Bhd, has signed a five-year agreement to provide offshore maintenance and modification services to Brunei Shell Petroleum (BSP). Scope of work covers maintenance and upgrades to maintain production levels for more than 200 offshore assets. The name of the new entity is PTAS Aker Solutions Sdn Bhd. The joint venture will ensure continuity of delivery to BSP and has a strong local execution capability, combined with the full value of Aker Solutions’ international expertise. The work will be managed from PTAS Aker

Vicore submits clinical trial application for phase II trial with C21 in IPF

Gothenburg, March 30, 2020 – Vicore Pharma, a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces submission of the clinical trial application (CTA) for a proof-of-concept study with its proprietary compound C21 in patients with IPF (idiopathic pulmonary fibrosis) to the UK regulatory agency MHRA.The phase II clinical study in patients with IPF will be a six months single arm open label study which will compare the effect of C21 to the well documented linear decline of lung function in untreated patients. It will also be possible to,

OssDsign receives regulatory approval and prepares for launch in Japan

OssDsign AB (publ) today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of OssDsign Cranial PSI for the Japanese market. OssDsign plans to launch OssDsign Cranial PSI in Japan together with a national distribution partner immediately following formal reimbursement approval which is expected within the next two quarters.As previously communicated, OssDsign has been pursuing a regulatory application in Japan since June 2019. The recent notice of regulatory approval from the PMDA is highly significant for OssDsign as the Japanese market for

COVID-19’s Effects on Stille

Stille AB (publ) informs about how the company is affected by the COVID-19 outbreak.After the publication of the year-end report on the 20th of February, uncertainty relating to the COVID-19 outbreak has increased. Changed priorities within the healthcare system, and actions to slow the spread of the virus is increasingly affecting the business. In line with the increased number of cases, the healthcare system is realigning their focus from surgery to intensive care, which has a considerable impact on the market’s demand for Stille’s products. Because of this reason, Stille believes that

InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2019

March 30, 2020 – InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2019. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website, https://www.indexpharma.com/en/category/annual-reports/.The printed Annual Report is mailed to shareholders and other stakeholders who specifically request it. Send request to info@indexpharma.com, or by mail to InDex Pharmaceuticals Holding AB (publ), Tomtebodavägen 23a, 171 77 Stockholm.   For more information: Peter Zerhouni, CEOPhone: +46 8 508 847 35E-mail: peter.

SSAB to initiate employer-employee negotiations in its Finnish operations

SSAB has decided to initiate employer-employee negotiations concerning temporary layoffs in its Finnish operations following weakened market conditions as a result of the Covid-19 pandemic. The negotiations apply to SSAB Group’s personnel in Finland, excluding subsidiaries Ruukki Construction and Tibnor.The exact number of employees affected as well as the lengths of the temporary lay-offs will be decided in the negotiations. Any temporary layoffs would begin in week 16 at the earliest. For more information, please contactAtte Kaksonen, Press Officer, Finland, atte.kaksonen @ ssab.com,

Storebrand Bank ASA: Annual Report 2019

The bank group achieved a profit before tax of NOK 272 million for 2019, compared with NOK 199 million in 2018 for continued operations. The principal reason for the improvement in profit from 2018 was increased net interest income of NOK 58 million compared with 2018 due to increased deposit margins. Other operating income increased by NOK 15 million in 2019, compared with the previous year as a result of increased profits on financial instruments at fair value. Operating expenses ended at NOK 7 million higher in 2019 than in 2018 through increased depreciation and write-downs on

Storebrand Boligkreditt AS: Annual Report 2019

The company’s operating profit before losses for 2019 was NOK 82 million (NOK 76 million). Net losses on lending was NOK 0 million (cost of NOK 1 million). Profit after tax for Storebrand Boligkreditt AS in 2019 was NOK 64 million, compared to NOK 57 million for 2018. Lysaker, 30 March 2020 For further information contact:Acting Managing Director, Einar Leikanger, mobile +47 9342 0379Group Head of Finance, Strategy and M&A, Kjetil Ramberg Krøkje, mobile +47 934 12 155Head of Investor Relations and Rating, Daniel Sundahl, mobile +47 913 61 899 This information is subject of

Storebrand ASA: Annual Report 2019

Storebrand ASA makes public the annual report for 2019 today. The annual report is available on Storebrand's web site: www.storebrand.com/ir. Lysaker, 30 March 2020 Contacts: Head of Investor Relations, Daniel Sundahl: Tel +47 913 61 899 Storebrand's ambition is to be the best provider of saving for pensions. Storebrand will deliver sustainable solutions adapted to the customer's individual situation, so that each person receives a better pension in a more sustainable world. Storebrand has about 40.000 corporate customers and 2 million individual customers, and has its

Peab builds senior living in Eskilstuna

Peab has been commissioned to build senior living with 88 apartments in city district Skiftinge in Eskilstuna. The customer is Eskilstuna Municipality and the contract is worth SEK 175 million.Peab will build a senior living center of more than 9,000 m2 in Skiftinge. It will be one building with three wings and a connecting section in the middle. The center will contain 88 apartments, administration and staff space as well as public and communal areas. Peab is already building a new preschool and renovating and extending Skiftingehus School. The project is a turnkey contract.

Induct - Registration of share capital increase

Reference is made to stock exchange announcement by Induct AS ("Induct" or the "Company") on 31 December 2019 regarding completion of Private Placement of NOK 2 million by NPP Capital AS, a company 100% owned by Alf Martin Johansen, Induct's CEO. The share capital increase pertaining to the Private Placement has now been registered with the Norwegian Register of Business Enterprises. The share capital has been increased with NOK 50,000 through issuance of 500,000 new shares, each with a par value of NOK 0.10. The Company's new share capital is thus NOK 1,191,003 divided by 11,910,030

Invitation to a Company Update on the COVID-19 Response

LUND (Sweden) - Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, April 1, 2020 at 16:30 CET. Mats Grahn, CEO will present an update on the company’s COVID-19 response as well as an update on the activities in preparation for the Q3 2020 launch of IMMray™ PanCan-d and the prospective studies followed by a Q&A session. Please call in a few minutes in advance. To attend, please dial-in at one of the numbers below and provide the conference code Immunovia to the operator: Conference Numbers: Sweden: +46 (0) 8 50 520 424 Austria:

Annual General Meeting in ASSA ABLOY AB

ASSA ABLOY AB will hold the Annual General Meeting on Wednesday 29 April 2020 at 3.30 p.m., at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4, Stockholm, Sweden. Please note that the premises is different than previously set out. Due to the Covid-19 pandemic, ASSA ABLOY has decided to take the following precautionary measures in connection with the Annual General Meeting in consideration of the health and safety of our shareholders, employees and other stakeholders: - Registration will not start until 3.00 p.m.- No food or beverages will be served.- There will be no

Betsson AB postpones the Annual General Meeting

The Board of Directors in Betsson AB has decided to postpone the Annual General Meeting (AGM) due to the Public Health Agency of Sweden’s (Folkhälsomyndigheten) recommendations to limit the spread of COVID-19.On March 27, Folkhälsomyndigheten proposed that the number of participants in public gatherings should be limited to 50 people. Betsson AB choses to follow the recommendation as a measure to limit the spread of COVID-19 and is therefore postponing the AGM from 28 April to 11 June, hoping that the situation with the virus has then improved. The AGM will be held 9 AM at Bond, GT30, Grev

Senzime secures the first sales in the US market

News: Uppsala, March 30, 2020. Senzime AB (publ) today announces that the company has received its first orders in the US which marks the sales start in the fully owned subsidiary Senzime Inc. In October 2019 Senzime announced that the company's medical device system for monitoring neuromuscular blockade, TetraGraph, had received 510 (k) approval by the US Food and Drug Administration, FDA. Senzime immediately began the establishment of a fully owned subsidiary - Senzime Inc. - which was registered in Florida in early December 2019 at the same time as the recruitment of a head of US

Board decides on revised proposal for dividend

The Board considers that the ongoing global Covid-19 pandemic involves considerable uncertainty about the future market situation. ASSA ABLOY´s financial position is strong and the Group has initiated cost saving measures to counter the uncertain market situation. In the Quarterly Report for the fourth quarter 2019 and in the Annual Report 2019, the Board has communicated its proposal of a dividend of SEK 3.85 per share for the financial year 2019. In light of the uncertainty in the market caused by the Covid-19 pandemic the Board has today, as a precautionary measure, decided to revise

There are no items matching the current filter
There are no more items matching the current filter
Back to top